Bigfoot’s diabetes management system is designed to address problems such as missed doses, inadequate insulin intensification and dosing errors that affect people with diabetes who
Sernova has entered into a preclinical research collaboration on drug delivery with AstraZeneca, with the aim of evaluating the use of Sernova’s Cell Pouch System
Hundreds of British children with Type 2 diabetes who currently manage their condition with ‘burdensome’ finger prick blood testing several times a day could be
A potential stem cell–derived pancreatic islet cell replacement therapy (VX-880, from Vertex Pharmaceuticals) continues to show promise as a treatment for Type 1 diabetes, according
Roche has announced that real world data shows a significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr mobile
Insulet has announced the FDA clearance of Omnipod GO, an insulin delivery device cleared for use for people with tTpe 2 diabetes age 18 or
Because Great Britain never adopted the European Union’s Medical Devices Regulation (MDR) because its delayed date of application happened after the end of the Brexit
While mobile app developers have created a range of software tools to help people with diabetes manage their conditions, evidence to support mobile health apps
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for individuals 6 years of age and older with
Owen Mumford’s Aidaptus single-use auto-injector has been awarded a distinction in the prestigious Red Dot awards for innovative product design. It is a versatile and
